Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Peapod Bio is a private contract research organization focused on assay development, high-throughput screening, and hit-discovery support for small molecule drug discovery programs. The company positions itself as a rapid-turnaround partner for biochemical assays, using label-free and orthogonal technologies built around high-throughput MALDI mass spectrometry. Its services appear geared toward pharma and biotech customers rather than development of an internal therapeutic pipeline. Peapod Bio also offers access to screening workflows that can incorporate external compound libraries through strategic collaborations. Overall, the company is best characterized as an enabling drug discovery services company rather than a therapeutic developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Peapod.